The Shareholders Foundation, Inc. announces an update in the lawsuit that is pending for certain investors in QuidelOrtho Corporation (NASDAQ:QDEL) shares. Investors in NASDAQ:QDEL shares should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

The Shareholders Foundation, Inc. announces an update in the lawsuit that is pending for certain investors in QuidelOrtho Corporation (NASDAQ:QDEL) shares.

mail@shareholdersfoundation.com
mail@shareholdersfoundation.com
Shareholders Foundation – mail@shareholdersfoundation.com or +1(858) 779 – 1554.

Investors who purchased shares of QuidelOrtho Corporation (NASDAQ:QDEL) and continue to hold any of those NASDAQ:QDEL shares have also certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

On April 12, 2024, an investor in NASDAQ:QDEL shares filed a lawsuit against QuidelOrtho Corporation over alleged securities laws violations. The plaintiff alleged that the defendants misled investors by making statements that were false and misleading when made because they knew or deliberately disregarded and failed to disclose the following adverse facts about QuidelOrtho’s business, operations, and prospects that QuidelOrtho sold more COVID-19 tests to its distributors and pharmacy chain customers than they could resell to healthcare providers and end customers, that excess inventories of COVID-19 tests existed throughout the supply chain, that, as a result of (a)-(b), QuidelOrtho’s distributors and pharmacy chain customers were poised to significantly reduce their COVID-19 test orders, that undisclosed problems created a heightened risk that the Savanna RVP4 Test would experience a delayed commercial launch in the United States, and that, as a result of (a)-(d), Defendants lacked a reasonable basis for their positive statements about QuidelOrtho’s business, financials, and growth trajectory.

On April 25, 2024, and June 21, 2024, two investors in shares of QuidelOrtho Corporation filed stockholder derivative lawsuit against certain directors of QuidelOrtho Corporation over alleged breaches of fiduciary duties.

Those who purchased shares of QuidelOrtho Corporation (NASDAQ:QDEL) should contact the Shareholders Foundation, Inc.

CONTACT:
Shareholders Foundation, Inc.
Michael Daniels
+1 (858) 779-1554
mail@shareholdersfoundation.com
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

Contact Information
Michael Daniels
Manager
mail@shareholdersfoundation.com
858-779-1554

SOURCE: Shareholders Foundation, Inc.

Source: Shareholders Foundation, Inc.

Related Media



Source link


administrator

Leave a Reply

Your email address will not be published. Required fields are marked *